Meitav Investment House’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,776
| Closed | -$322K | – | 533 |
|
|
2023
Q1 | $322K | Hold |
4,776
| – | – | 0.01% | 313 |
|
|
2022
Q4 | $344K | Hold |
4,776
| – | – | 0.01% | 313 |
|
|
2022
Q3 | $340K | Hold |
4,776
| – | – | 0.01% | 312 |
|
|
2022
Q2 | $368K | Buy |
+4,776
| New | +$368K | 0.01% | 291 |
|
|
2022
Q1 | – | Sell |
-4,606
| Closed | -$287K | – | 386 |
|
|
2021
Q4 | $287K | Buy |
4,606
+605
| +15% | +$37.7K | ﹤0.01% | 348 |
|
|
2021
Q3 | $237K | Sell |
4,001
-18,474
| -82% | -$1.09M | ﹤0.01% | 368 |
|
|
2021
Q2 | $1.5M | Buy |
22,475
+18,475
| +462% | +$1.23M | 0.04% | 199 |
|
|
2021
Q1 | $253 | Sell |
4,000
-900
| -18% | -$57 | 0.01% | 337 |
|
|
2020
Q4 | $303K | Sell |
4,900
-700
| -13% | -$43.3K | 0.01% | 337 |
|
|
2020
Q3 | $336K | Buy |
+5,600
| New | +$336K | 0.02% | 314 |
|
|
2020
Q1 | – | Sell |
-6,100
| Closed | -$391K | – | 386 |
|
|
2019
Q4 | $391K | Buy |
6,100
+1,900
| +45% | +$122K | 0.03% | 266 |
|
|
2019
Q3 | $209K | Buy |
+4,200
| New | +$209K | 0.02% | 406 |
|